» Articles » PMID: 38242997

Impact of Intratumoral Microbiome on Tumor Immunity and Prognosis in Human Pancreatic Ductal Adenocarcinoma

Abstract

Background: Recent evidence suggests that the presence of microbiome within human pancreatic ductal adenocarcinoma (PDAC) tissue potentially influences cancer progression and prognosis. However, the significance of tumor-resident microbiome remains unclear. We aimed to elucidate the impact of intratumoral bacteria on the pathophysiology and prognosis of human PDAC.

Methods: The presence of intratumoral bacteria was assessed in 162 surgically resected PDACs using quantitative polymerase chain reaction (qPCR) and in situ hybridization (ISH) targeting 16S rRNA. The intratumoral microbiome was explored by 16S metagenome sequencing using DNA extracted from formalin-fixed paraffin-embedded tissues. The profile of intratumoral bacteria was compared with clinical information, pathological findings including tumor-infiltrating T cells, tumor-associated macrophage, fibrosis, and alterations in four main driver genes (KRAS, TP53, CDKN2A/p16, SMAD4) in tumor genomes.

Results: The presence of intratumoral bacteria was confirmed in 52 tumors (32%) using both qPCR and ISH. The 16S metagenome sequencing revealed characteristic bacterial profiles within these tumors, including phyla such as Proteobacteria and Firmicutes. Comparison of bacterial profiles between cases with good and poor prognosis revealed a significant positive correlation between a shorter survival time and the presence of anaerobic bacteria such as Bacteroides, Lactobacillus, and Peptoniphilus. The abundance of these bacteria was correlated with a decrease in the number of tumor-infiltrating T cells positive for CD4, CD8, and CD45RO.

Conclusions: Intratumoral infection of anaerobic bacteria such as Bacteroides, Lactobacillus, and Peptoniphilus is correlated with the suppressed anti-PDAC immunity and poor prognosis.

Citing Articles

Upregulation of . in gut microbiota as a novel mechanism for environmental eustress-induced anti-pancreatic cancer effects.

Liang Y, Du M, Li X, Gao J, Li Q, Li H Gut Microbes. 2025; 17(1):2470372.

PMID: 39988618 PMC: 11853549. DOI: 10.1080/19490976.2025.2470372.


Therapeutic potential of garlic, aged garlic extract and garlic‑derived compounds on pancreatic cancer (Review).

Kawasaki H, Nussbaum G Biomed Rep. 2025; 22(3):54.

PMID: 39926043 PMC: 11803370. DOI: 10.3892/br.2025.1932.


Revisiting the cancer microbiome using PRISM.

Ghaddar B, Blaser M, De S bioRxiv. 2025; .

PMID: 39896561 PMC: 11785023. DOI: 10.1101/2025.01.21.634087.


Gut Microbiota-Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer.

Said S, Ibrahim W Cancer Manag Res. 2025; 17:171-192.

PMID: 39881948 PMC: 11776928. DOI: 10.2147/CMAR.S405590.


Exploring the microbiome-gut-testis axis in testicular germ cell tumors.

Ciernikova S, Sevcikova A, Mego M Front Cell Infect Microbiol. 2025; 14():1529871.

PMID: 39850963 PMC: 11754299. DOI: 10.3389/fcimb.2024.1529871.


References
1.
Foucher E, Ghigo C, Chouaib S, Galon J, Iovanna J, Olive D . Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment. Front Immunol. 2018; 9:1044. PMC: 5960705. DOI: 10.3389/fimmu.2018.01044. View

2.
Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W . Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell. 2019; 178(4):795-806.e12. PMC: 7288240. DOI: 10.1016/j.cell.2019.07.008. View

3.
Harada Y, Sujino T, Miyamoto K, Nomura E, Yoshimatsu Y, Tanemoto S . Intracellular metabolic adaptation of intraepithelial CD4CD8αα T lymphocytes. iScience. 2022; 25(4):104021. PMC: 8933710. DOI: 10.1016/j.isci.2022.104021. View

4.
Callahan B, McMurdie P, Rosen M, Han A, Johnson A, Holmes S . DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016; 13(7):581-3. PMC: 4927377. DOI: 10.1038/nmeth.3869. View

5.
Thomas R, Gharaibeh R, Gauthier J, Beveridge M, Pope J, Guijarro M . Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models. Carcinogenesis. 2018; 39(8):1068-1078. PMC: 6067127. DOI: 10.1093/carcin/bgy073. View